STERIS’s stock price has taken a beating over the past six months, shedding 20.4% of its value and falling to $202.39 per share. This might have investors co...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
STERIS delivered Q1 results that met Wall Street’s revenue expectations, with the market reacting positively to the company’s performance. Management pointed...
STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.
Senior Vice P
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Medical equipment and services company Steris (NYSE:STE). met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.3% year on year to $1.59 billi...
Medical equipment and services company Steris (NYSE:STE). met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.3% year on year to $1.59 billi...
Medical equipment and services company Steris (NYSE:STE). will be reporting results this Monday after the bell. Here’s what you need to know. STERIS beat ana...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged...
Over the past six months, STERIS’s stock price fell to $214.47. Shareholders have lost 11.3% of their capital, which is disappointing considering the S&P 500...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at STERIS (NYSE:STE) and its pee...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, incl...
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
